The role of oxidative stress on the pathogenesis of Graves' disease

Journal of Thyroid Research

Volumn 2012, Issue , 2012, Pages

  Žarković, Miloš ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 8 HYDROXYDEOXYGUANOSINE; 8 OXOGUANINE DNA N GLYCOSYLASE 1; ACETYLCYSTEINE; ALLOPURINOL; DNA GLYCOSYLTRANSFERASE; GENOMIC DNA; GLUCOCORTICOID; MALONALDEHYDE; METHYLPREDNISOLONE; NICOTINAMIDE; PLACEBO; PROPYLTHIOURACIL; REACTIVE OXYGEN METABOLITE; SODIUM SELENITE; THIAMAZOLE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; CELL PROLIFERATION; DISEASE ASSOCIATION; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; ENDOCRINE OPHTHALMOPATHY; GENE; GRAVES DISEASE; HUMAN; LIPID PEROXIDATION; NONHUMAN; OGG1 GENE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

EID: 84872733186     PISSN: 20908067     EISSN: 20420072     Source Type: Journal    
DOI: 10.1155/2012/302537     Document Type: Review

References (53)

1. Laurberg P., Pedersen K. M., Vestergaard H., Sigurdsson G., High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. Journal of Internal Medicine 1991 229 5 415 420 2-s2.0-0025851976
2. Wiersinga W. M., Bartalena L., Epidemiology and prevention of Graves' ophthalmopathy. Thyroid 2002 12 10 855 860 2-s2.0-0036808952 (Pubitemid 35332989)
3. Smith T. J., Pathogenesis of Graves' orbitopathy: a 2010 update. Journal of Endocrinological Investigation 2010 33 6 414 421 2-s2.0-77955375528
4. Sies H., Oxidative stress: oxidants and antioxidants. Experimental Physiology 1997 82 2 291 295 2-s2.0-0030894162 (Pubitemid 27182306)
5. Valko M., Leibfritz D., Moncol J., Cronin M. T. D., Mazur M., Telser J., Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry and Cell Biology 2007 39 1 44 84 2-s2.0-33749986298 10.1016/j.biocel.2006.07.001 (Pubitemid 44566469)
6. Matés J. M., jmates@uma.es Pérez-Gómez C., de Castro I. N., Antioxidant enzymes and human diseases. Clinical Biochemistry 1999 32 8 595 603 10.1016/S0009-9120(99)00075-2 (Pubitemid 30039087)
7. Larsen P. R., Davies T. F., Schlumberger M., Hay I. D., Kronenberg H. M., Melmed S., Polonsky K. S., Larsen P. R., 10. Williams Textbook of Endocrinology 2008 Saunders Elsevier 299 332
8. Song Y., Driessens N., Costa M., De Deken X., Detours V., Corvilain B., Maenhaut C., Miot F., Van Sande J., Many M. C., Dumont J. E., Roles of hydrogen peroxide in thyroid physiology and disease. The Journal of Clinical Endocrinology and Metabolism 2007 92 10 3764 3773 2-s2.0-35348944457 10.1210/jc.2007-0660 (Pubitemid 47607620)
9. Gérard A. C., Many M. C., Daumerie C., Knoops B., Colin I. M., Peroxiredoxin 5 expression in the human thyroid gland. Thyroid 2005 15 3 205 209 2-s2.0-15744401552 10.1089/thy.2005.15.205 (Pubitemid 40418687)
10. Mono T., Shinohara R., Iwase K., Kotake M., Hamada M., Uchimura K., Hayakawa N., Hayashi R., Nakai A., Ishizuki Y., Nagasaka A., Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Hormone and Metabolic Research 1997 29 7 351 354 2-s2.0-8544225019 (Pubitemid 27362010)
11. Poncin S., Colin I. M., Decallonne B., Clinckspooor I., Many M. -C., Denef J. -F., Gérard A. -C., anne-catherine.gerard@uclouvain.be N-acetylcysteine and 15 deoxy-Δ12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1 α /interferon γ -induced inhibitory effects in thyrocytes in vitro. The American Journal of Pathology 2010 177 1 219 228 10.2353/ajpath.2010.091253
12. 2 generation is inhibited by iodide in human thyroids. The Journal of Clinical Endocrinology and Metabolism 2001 86 9 4339 4343 2-s2.0-0034853752 10.1210/jc.86.9.4339 (Pubitemid 32848556)
13. Knudsen N., Bülow I., Laurberg P., Ovesen L., Perrild H., Jorgensen T., Association of tobacco smoking with goiter in a low-iodine-intake area. Archives of Internal Medicine 2002 162 4 439 443 2-s2.0-0037169894 (Pubitemid 34150646)
14. Steinmaus C., Miller M. D., Howd R., Impact of smoking and thiocyanate on perchlorate and thyroid hormone associations in the 2001-2002 National Health and Nutrition Examination Survey. Environmental Health Perspectives 2007 115 9 1333 1338 2-s2.0-34748871419 10.1289/ehp.10300 (Pubitemid 47471258)
15. Poncin S., Gérard A. C., Boucquey M., Senou M., Calderon P. B., Knoops B., Lengelé B., Many M. C., Colin I. M., Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. Endocrinology 2008 149 1 424 433 2-s2.0-37549013371 10.1210/en.2007-0951
16. Abalovich M., Llesuy S., Gutierrez S., Repetto M., Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments. Clinical Endocrinology 2003 59 3 321 327 2-s2.0-0042827455 10.1046/j.1365-2265.2003.01850.x (Pubitemid 37046985)
17. Ademolu E., Özbey N., Erbil Y., yerbil2003@yahoo.com Tanrikulu S., Barbaros U., Yanik B. T., Bozbora A., Özarmaan S., Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease. European Journal of Internal Medicine 2006 17 8 545 550 10.1016/j.ejim.2006.04. 013 (Pubitemid 44827700)
18. Venditti P., Di Meo S., Thyroid hormone-induced oxidative stress. Cellular and Molecular Life Sciences 2006 63 4 414 434 2-s2.0-33645073403 10.1007/s00018-005-5457-9
19. Cetinkaya A., Kurutas E. B., Buyukbese M. A., Kantarceken B., Bulbuloglu E., Levels of malondialdehyde and superoxide dismutase in subclinical hyperthyroidism. Mediators of Inflammation 2005 2005 1 57 59 2-s2.0-21744451518 10.1155/MI.2005.57 (Pubitemid 40942912)
20. Nandakumar D. N., Koner B. C., Vinayagamoorthi R., Nanda N., Negi V. S., Goswami K., Bobby Z., Hamide A., Activation of NF- κ B in lymphocytes and increase in serum immunoglobulin in hyperthyroidism: possible role of oxidative stress. Immunobiology 2008 213 5 409 415 2-s2.0-42949137392 10.1016/j.imbio. 2007.10.005 (Pubitemid 351619288)
21. Makay B., Makay O., Yenisey C., Icoz G., Ozgen G., Unsal E., Akyildiz M., Yetkin E., The interaction of oxidative stress response with cytokines in the thyrotoxic ratpIs there a link? Mediators of Inflammation 2009 2009 7 2-s2.0-65349110305 10.1155/2009/391682 391682
22. Vrca V. B., Skreb F., Cepelak I., Romic Z., Mayer L., Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium. Clinica Chimica Acta 2004 341 1-2 55 63 2-s2.0-1142309611 10.1016/j.cccn.2003.10.028 (Pubitemid 38210314)
23. Bednarek J., Wysocki H., Sowiski J., Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy. Clinical Biochemistry 2005 38 1 13 18 2-s2.0-10644260599 10.1016/j.clinbiochem.2004.09.015 (Pubitemid 39647650)
24. Messarah M., Boumendjel A., Chouabia A., Klibet F., Abdennour C., Boulakoud M. S., Feki A. E., Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats. Experimental and Toxicologic Pathology 2010 62 3 301 310 2-s2.0-77952891501 10.1016/j.etp.2009. 04.009
25. Chattopadhyay S., Sahoo D. K., Roy A., Samanta L., Chainy G. B. N., Thiol redox status critically influences mitochondrial response to thyroid hormone-induced hepatic oxidative injury: a temporal analysis. Cell Biochemistry and Function 2010 28 2 126 134 2-s2.0-77249152225 10.1002/cbf.1631
26. Sahoo D. K., Roy A., Bhanja S., Chainy G. B. N., Experimental hyperthyroidism-induced oxidative stress and impairment of antioxidant defence system in rat testis. Indian Journal of Experimental Biology 2005 43 11 1058 1067 2-s2.0-27644599398 (Pubitemid 41579262)
27. Zamoner A., Barreto K. P., Filho D. W., Sell F., Woehl V. M., Guma F. C. R., Silva F. R. M. B., Pessoa-Pureur R., Hyperthyroidism in the developing rat testis is associated with oxidative stress and hyperphosphorylated vimentin accumulation. Molecular and Cellular Endocrinology 2007 267 1-2 116 126 2-s2.0-33847262102 10.1016/j.mce.2007.01.005
28. Mogulkoc R., Baltaci A. K., Oztekin E., Ozturk A., Sivrikaya A., Short-term thyroxine administration leads to lipid peroxidation in renal and testicular tissues of rats with hypothyroidism. Acta Biologica Hungarica 2005 56 3-4 225 232 2-s2.0-24144501558 10.1556/ABiol.56.2005.3-4.6 (Pubitemid 41238270)
29. Moulakakis K. G., Poulakou M. V., Paraskevas K. I., Dontas I., Vlachos I. S., Sokolis D. P., Dosios T., Karayannacos P. E., Perrea D., Hyperthyroidism is associated with increased aortic oxidative DNA damage in a rat model. In Vivo 2007 21 6 1021 1026 2-s2.0-37349022945 (Pubitemid 350286329)
30. Araujo A. S. R., Ribeiro M. F. M., Enzveiler A., Schenkel P., Fernandes T. R. G., Partata W. A., Irigoyen M. C., Llesuy S., Belló-Klein A., Myocardial antioxidant enzyme activities and concentration and glutathione metabolism in experimental hyperthyroidism. Molecular and Cellular Endocrinology 2006 249 1-2 133 139 2-s2.0-33645874214 10.1007/s11269-006-4635-3 (Pubitemid 43192983)
31. Araujo A. S. R., Schenkel P., Enzveiler A. T., Fernandes T. R. G., Partata W. A., Llesuy S., Ribeiro M. F. M., Khaper N., Singal P. K., Belló-Klein A., The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism. Journal of Molecular Endocrinology 2008 41 6 423 430 2-s2.0-57749086758 10.1677/JME-08-0024
32. Araujo A. S., Fernandes T., Ribeiro M. F., Khaper N., Belló-Klein A., Redox regulation of myocardial Erk 1/2 phosphorylation in experimental hyperthyroidism: role of thioredoxin-peroxiredoxin system. Journal of Cardiovascular Pharmacology 2010 56 5 513 517 2-s2.0-78650170566 10.1097/FJC.0b013e3181f50a70
33. Pantos C., Malliopoulou V., Mourouzis I., Thempeyioti A., Paizis I., Dimopoulos A., Saranteas T., Xinaris C., Cokkinos D. V., Hyperthyroid hearts display a phenotype of cardioprotection against ischemic stress: a possible involvement of heat shock protein 70. Hormone and Metabolic Research 2006 38 5 308 313 2-s2.0-33744972132 10.1055/s-2006-925404 (Pubitemid 43864951)
34. Yamada T., Mishima T., Sakamoto M., Sugiyama M., Matsunaga S., Wada M., Oxidation of myosin heavy chain and reduction in force production in hyperthyroid rat soleus. Journal of Applied Physiology 2006 100 5 1520 1526 2-s2.0-33646409838 10.1152/japplphysiol.01456.2005
35. Eckstein A. K., Johnson K. T., Thanos M., Esser J., Ludgate M., Current insights into the pathogenesis of Graves' orbitopathy. Hormone and Metabolic Research 2009 41 6 456 464 2-s2.0-68149156416 10.1055/s-0029-1220935
36. Burch H. B., Lahiri S., Bahn R. S., Barnes S., Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy. Experimental Eye Research 1997 65 2 311 316 2-s2.0-0030872121 10.1006/exer.1997.0353 (Pubitemid 27360161)
37. Hiromatsu Y., Yang D., Miyake I., Koga M., Kameo J., Sato M., Inoue Y., Nonaka K., Nicotinamide decreases cytokine-induced activation of orbital fibroblasts from patients with thyroid-associated ophthalmopathy. The Journal of Clinical Endocrinology and Metabolism 1998 83 1 121 124 2-s2.0-0031795562 10.1210/jc.83.1.121 (Pubitemid 28498321)
38. Hondur A., Konuk O., Dincel A. S., Bilgihan A., Unal M., Hasanreisoglu B., Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy. Current Eye Research 2008 33 5-6 421 427 2-s2.0-47349098852 10.1080/02713680802123532 (Pubitemid 351998840)
39. Lu R., Wang P., Wartofsky L., Sutton B. D., Zweier J. L., Bahn R. S., Garrity J., Burman K. D., Oxygen free radicals in interleukin-1 β -induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves' ophthalmopathy patients. Thyroid 1999 9 3 297 303 2-s2.0-0032932078 (Pubitemid 29171781)
40. Tsan M. F., Gao B., Heat shock proteins and immune system. Journal of Leukocyte Biology 2009 85 6 905 910 2-s2.0-67149133632 10.1189/jlb.0109005
41. Williams J. H. H., Ireland H. E., Sensing dangerhsp72 and hmgb1 as candidate signals. Journal of Leukocyte Biology 2008 83 3 489 492 2-s2.0-43349107048 10.1189/jlb.0607356 (Pubitemid 351966855)
42. Heufelder A. E., Wenzel B. E., Bahn R. S., Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts. The Journal of Clinical Endocrinology and Metabolism 1992 74 4 737 742 2-s2.0-0026582956 10.1210/jc.74.4.737
43. Tsai C. C., Wu S. B., Cheng C. Y., Kao S. C., Kau H. C., Chiou S. H., Hsu W. M., Wei Y. H., Increased oxidative DNA damage, lipid peroxidation, and reactive oxygen species in cultured orbital fibroblasts from patients with Graves ophthalmopathy: evidence that oxidative stress has a role in this disorder. Eye 2010 24 9 1520 1525 2-s2.0-77956607518 10.1038/eye.2010.31
44. Tsai C. C., Cheng C. Y., Liu C. Y., Kao S. C., Kau H. C., Hsu W. M., Wei Y. H., Oxidative stress in patients with Graves' ophthalmopathy: relationship between oxidative DNA damage and clinical evolution. Eye 2009 23 8 1725 1730 2-s2.0-69049086942 10.1038/eye.2008.310
45. Thornton J., Kelly S. P., Harrison R. A., Edwards R., Cigarette smoking and thyroid eye disease: a systematic review. Eye 2007 21 9 1135 1145 2-s2.0-34548534955 10.1038/sj.eye.6702603 (Pubitemid 47382137)
46. Tanrikulu S., Doru-Abbasolu S., sdabbasoglu@yahoo.com Özderya A., Ademolu E., Karada B., Erbil Y., Uysal M., The 8-oxoguanine DNA N-glycosylase 1 (hOGG1) Ser326Cys variant affects the susceptibility to Graves' disease. Cell Biochemistry and Function 2011 29 3 244 248 10.1002/cbf.1742
47. Tsai C. C., Kao S. C., Cheng C. Y., Kau H. C., Hsu W. M., Lee C. F., Wei Y. H., Oxidative stress change by systemic corticosteroid treatment among patients having active graves ophthalmopathy. Archives of Ophthalmology 2007 125 12 1652 1656 2-s2.0-37149024272 10.1001/archopht.125.12.1652 (Pubitemid 350254879)
48. Akarsu E., Buyukhatipoglu H., Aktaran., Kurtul N., Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy. Clinical Endocrinology 2011 74 1 118 124 2-s2.0-78650360042 10.1111/j.1365-2265.2010.03904.x
49. Bouzas E. A., Karadimas P., Mastorakos G., Koutras D. A., Antioxidant agents in the treatment of Graves' ophthalmopathy. American Journal of Ophthalmology 2000 129 5 618 622 2-s2.0-0034126183 10.1016/S0002-9394(00)00359-7 (Pubitemid 30323727)
50. Rayman M. P., The importance of selenium to human health. The Lancet 2000 356 9225 233 241 2-s2.0-0034662094 (Pubitemid 30446984)
51. Duntas L. H., Selenium and the thyroid: a close-knit connection. The Journal of Clinical Endocrinology and Metabolism 2010 95 12 5180 5188 2-s2.0-78650056003 10.1210/jc.2010-0191
52. Marcocci C., claudio.marcocci@med.unipi.it Kahaly G. J., Krassas G. E., Bartalena L., Prummel M., Stahl M., Altea M. A., Nardi M., Pitz S., Boboridis K., Sivelli P., Von Arx G., Mourits M. P., Baldeschi L., Bencivelli W., Wiersinga W., Selenium and the course of mild Graves' orbitopathy. The New England Journal of Medicine 2011 364 20 1920 1931 10.1056/NEJMoa1012985
53. Bartalena L., Tanda M. L., Piantanida E., Lai A., Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implications. BioFactors 2003 19 3-4 155 163 2-s2.0-0842264910 (Pubitemid 38175119)